PLOD1 and polycystic ovary syndrome: Recent clinical studies reported that treatment with AZD4901, a neurokinin-3 receptor antagonist, specifically reduced LH pulse frequency and subsequent serum concentrations of LH and testosterone in PCOS women (133).